Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 386 - файл
.pdf
216
https://t.me/medicina_free
J. H. Bortz and H. Friedrich-Nel
the tumour and minimise the exposure of chemotherapy to the normal surrounding tissue.
Chemotherapy may cause side effects such as
vomiting, nausea, diarrhoea, neuropathy, or
mouth sores. A patient may also feel tired, with
an increased risk of infection. Other side effects
include neuropathy, tingling, or numbness in feet
or hands. Side effects are drug dependent and can
be treated with prescribed medication [34].
15.8 Radiation Therapy
External-beam radiation therapy is commonly
used for patients with CRC and can take various
forms [34]. Endocavitary therapy is applied via
the anus and is sometimes used in combination
with external-beam radiation therapy.
Brachytherapy uses small sources of radioactive
material inserted in a tube and placed in or next to
the tumour. The advantage of brachytherapy is
the high dose to the tumour while the radiation
dose to the normal surrounding healthy tissues is
minimised. A last radiation therapy treatment
option is radioembolisation which is radiation
therapy during an embolisation procedure.
Preoperative pelvic radiotherapy, with a biologically effective dose of 30Gy or higher, in combination with surgery has shown to improve the
local control of the tumour. A short course of preoperative radiotherapy (e.g., 25Gy in 5 fractions)
can reduce the risk of local recurrence.
Side effects from radiation therapy depend on
the size of the area being treated as well as the
dose. The effects may include fatigue, mild skin
reactions, an upset stomach, and loose bowel
movements. Bloody stools from bleeding through
the rectum or a blockage of the bowel may also
be present. Most of the side effects will disappear
as soon as the radiation therapy stops [34].
cancer has not grown beyond the inner lining of
the bowel. The cancer is local and does not
involve surrounding or nearby lymph tissue.
Surgery includes any of the following: polypectomy, local excision through colonoscope, or
colectomy.
• For stage I tumours, surgery remains the main
treatment option. No other treatment is
required if the polyp or tumour is completely
removed as indicated by the histopathology
report.
• Stage II cancers have grown through the walls
of the bowel and may extend into the surrounding tissue but may not be present in the
nearby lymph nodes. Recommended therapy
includes surgery with adjuvant chemotherapy,
specically for those tumours with a moderate
to high risk of local recurrence. Radiation
therapy may also be an option if there is a risk
of local recurrence.
• Stage III cancer has spread to the nearby
lymph nodes but not yet to distant sites such as
the liver and the lungs. Surgery is done to
remove the tumour, a section of the colon/rectum as well as the surrounding lymph nodes.
Surgery is then followed by adjuvant chemotherapy. In some cases, the patient may receive
chemotherapy before the surgery. If there is a
suspicion of local recurrence, radiation therapy may also be used. Radiation therapy and/
or chemotherapy remain a favourable treatment option for a patient who is not strong
enough for surgery.
• Stage IV CRC disease has spread to distant
organs and tissue such as the liver, peritoneum, lungs, and distant lymph nodes. These
patients will receive chemotherapy and/or targeted therapy to control the cancer. Radiation
therapy may be used to help relieve symptoms
such as pain.
15.8.1 Treatment ofCRC by Stage
There are four stages of CRC [34]. Each stage is
briey described. A stage 0 cancer means that the
Local or distant recurrence of the tumour is
treated with surgery, chemotherapy, and /or
radiation therapy as it depends on the site and
extent of the recurrence.

15 The Adenoma-Carcinoma Sequence, Management, andTreatment ofColon Cancer
https://t.me/medicina_free
217
15.9 Dual-Energy Computed
Tomography
The principle of dual-energy computed tomography (DECT) is based on the photo-electric effect
(low energy photon interactions) and Compton
effect (high energy photon interactions). These
phenomena facilitate the analysis of soft tissue,
calcium, and iodine [35]. Single or dual detectors
and single or double X-ray tube sources assist to
obtain data at two different energy levels, often
between 80 and 120kVp [35]. This results in qualitative and quantitative data of the tissue composition which facilitates the grouping of different
pathologies based on photon absorption and
Compton scattering at different energy levels [35].
The principles of DECT are discussed in Chap. 26.
The advantage of DECT is tissue differentiation, identication, and quantication. For example, iodine, calcium, or barium can be separated
from other tissues using one acquisition scan
[36]. Tissue identication and quantication
refer to assessment and the presence and amount
of, for example, iodine in a specic anatomical
region. The measurement of iodine content in tissue, for example, helps to differentiate between
benign and aggressive CRCs [37]. As such DECT
can also distinguish between stool and a polyp
without compromising the sensitivity and specicity of the examination [35, 38]. Additionally,
the iodine density measurements can also assist
in assessing treatment responses such as determining the size of the tumour in response to treatment. These features make DECT useful in
oncology imaging without an increase in the
radiation dose to the patient [36] (see Chap. 26).
Although CTC is regarded as a reliable screening
tool [39] and as a gold standard procedure
because of the high sensitivity, DECT has the
advantage that bowel preparation and/or bowel
distention of the patient is not required [35]. This
option is therefore pleasant for a patient and provides a positive patient experience [36].
Although DECT is unable to distinguish
between an adenoma and carcinoma, it is however useful for preoperative screening for CRCs.
Successful differentiation between metastatic
and non-metastatic lymph nodes of rectal cancer
was also reported [40, 41]. This is due to the
lower iodine concentration in metastatic lymph
nodes. DECT is useful for CRC grading [42].
15.10 Articial Intelligence for
Diagnosis andStaging ofCRC
A limitation of CTC is that a reader is not able to
differentiate benign and malignant lesions. Over
the past few years, the role of articial intelligence (AI) in medicine has been underscored.
For example, according to Yu and Helwig [43] AI
has a role for epidemiology of CRC as well as an
imaging tool for diagnosis of CRC. Literature
reports on the role of AI (machine learning/deep
learning) for polyp detection and differentiation
in imaging [44, 45]. In addition, literature
describes the use of AI in the diagnosis, staging,
and treatment of CRC [46, 47]. Kacew etal. [48]
are of the opinion that AI can contribute to cutting costs in CRC genotyping. A detailed discussion of AI and machine learning in imaging is
presented in Chap. 25.
15.11 AI Applications inRadiation
Therapy
Developments in the use of AI in radiation therapy were published recently in a review paper
[49]. Santoro etal. [49] retrieved 71 papers of
AI applications in radiation therapy planning.
These included three papers on iterative optimisation (IO), 25 papers on machine learning
(ML), and 43 papers on deep learning (DL).
The ML technique is used to identify patient
specic dose- volume constraints and custom
design radiation therapy options and solutions.
As these approaches may be time consuming
when done manually, utilising IO procedures
and auto- planning techniques can reduce the
treatment planning time. The advantage of this
approach is that there is a consistent production

218
https://t.me/medicina_free
J. H. Bortz and H. Friedrich-Nel
of quality plans with minimal inter-planning
variations [49].
Another application is for patient positioning
and monitoring, thus to verify that the patient
remains in the simulated treatment position.
DL-based methods are used that enable accurate
patient positioning. As such AI can be used for
dynamic motion management models to improve
tumour tracking. Irradiation can be interrupted if
there is patient motion, or inadequate target positioning. Such algorithms can track and accommodate real-time breathing motion to track the
tumour position in advance, adding to the accuracy and custom delivery of the radiation therapy
[49]. Santoro et al. [49] concluded that more
research is required to explore the use of AI, such
as auto-planning techniques and its application in
the clinical environment. Also, there is a need to
develop and implement reliable and trustworthy
AI tools as well as looking into the ethical principles implementing AI in the radiation therapy
environment. The WHO [50] underscores the
importance of key ethical principles of AI in
health.
Key Messages
• Most sporadic cancers arise from an adeno-
matous polyp.
• It takes between 10 and 15years for an ade-
noma to develop into a carcinoma.
• The adenoma-carcinoma pathway is of a can-
cer that arises from an adenomatous polyp.
• The serrated polyp-carcinoma sequence forms
between 15 and 20% of CRCs.
• The onset of CRC is increasing in younger
people.
• Treatment options for CRC include surgery,
chemotherapy, radiation therapy, and targeted
therapy that is usually offered in
combination.
• The treatment protocol depends on the stage
of the CRC and the performance status of the
patient.
• Chemotherapy and radiation therapy have side
effects. These symptoms can be treated with
prescribed medication.
• DECT may be useful for CRC grading.
• Diagnostic CTC, MRI, and PET/CT play a
role in TNM staging of CRC.
• Articial intelligence is playing an important
role in the diagnosis, treatment, and prognosis
of CRC.
15.12 Summary
Colorectal cancer (CRC) remains a major health
problem around the world. Apart from inherited
genetic disorders, such as hereditary nonpolyposis colorectal cancer, most CRCs arise
from a pre-existing polyp which develops over a
period of 10–15years into a cancer. Knowledge
of CRC pathways is important for reporting of
polyps detected during CTC studies.
Understanding treatment and management of
CRC underscore that concerted efforts should be
made to reduce persons developing CRC by correctly identifying and reporting advanced adenomas on CTC studies.
Acknowledgement Clinton Bopp is thanked for drawing
the target line diagram.
References
1. WHO. Cancer. 2022. [cited 2022 September 10].
https://www.who.int/news- room/fact- sheets/detail/
cancer.
2. WHO Implementation roadmap 2023–2030 for the
global action plan for the prevention and control of
NCDs 2013–2030. [cited 2022 September 10]. https://
www.who.int/teams/noncommunicable- diseases/
governance/roadmap.
3. American Society of Clinical Oncology. 2022.
[cited 2022 September 10]. https://www.cancer.net/
cancer- types/colorectal- cancer/statistics.
4. Rajagopalan A, Antoniou E, Rajagopalan E, Arachchi
A, Chouhan H, Nguyen TC, Teoh W.Is colorectal
cancer associated with altered bowel habits in young
patients? ANZ J Surg. 2021;91:943–6.
5. Kim J, Dobson B, Ng Liet Hing C, Cooper M, Lu CT,
Nolan G, Von Papen M. Increasing rate of colorectal cancer in younger patients: a review of colonoscopy ndings in patients under 50 at a tertiary
institution. ANZ J Surg. 2020;90:2484–9. https://doi.
org/10.1111/ans.16060.
6. Cavestro GM, Zuppardo RA, Mannucci A. Earlyonset of colorectal cancer: trends and challenges.

15 The Adenoma-Carcinoma Sequence, Management, andTreatment ofColon Cancer
https://t.me/medicina_free
219
Lancet Gastroenterol Hepatol. 2019;4(7):F491–2.
https://doi.org/10.1016/S2468- 1253(19)30146- 3.
7. Exarchakou A, Donaldson LJ, Girardi F, Coleman
MP.Colorectal cancer incidence among young adults
in England: trends by anatomical sub-site and deprivation. PLoS One. 2019;14(12):e0225547. https://doi.
org/10.1371/journal.pone.022554.
8. Araghi M, Soerjomataram I, Bardot A, Ferlay J,
Cabasag CJ, Morrison DS, De P, et al. Changes
in colorectal cancer incidence in seven highincome countries: a population-based study. Lancet
Gastroenterol Hepatol. 2019;4:511–8.
9. American Cancer Society. Guidelines for colorectal
cancer screening. [cited 2022 September 18]. https://
www.cancer.org/cancer/colon- rectal- cancer/detection.
10. Screening for colorectal cancer US Preventive
Services Task Force recommendation statement.
JAMA. 2021;325(19):1965–1977.
11. Johnson DA.Landmark developments in gastroenterology. Medscape. 2015. [cited 2022 September 10].
http://www.medscape.com.
12. Muto T, Bussey HJR, Morson BC. The evolution of
cancer of the colon and rectum. Cancer. 1975;36:2251–
70. https://doi.org/10.1002/cncr.2820360944.
13. Kim DH, Pickhardt PJ, Taylor AJ.Characteristics of
advanced adenomas detected at CT colonographic
screening: implication for appropriate size thresholds for polypectomy versus surveillance. AJR.
2007;188(4):940–4.
14. Bortz JH.CT colonography: an approach for a successful examination. S Afr J Rad. 2014;18(1):607, 11 pages.
https://doi.org/10.4102/sajr.v18i1.607SAJR2014.
15. Obaro AE, Burling D, Plumb AA. The role of imaging screening special feature: review article. Br J
Radiol. 2018;91:20180307. [cited 2022 September
10]. https://doi.org/10.1259/bjr.20180307.
16. Fillon M. Proximal serrated polyps increase the
future risk of colorectal cancer. CA Cancer J
Clin. 2020;70(5):317–8. https://doi.org/10.3322/
caac.21624.
17. Lynch HJ, de la Chapelle A. Genomic medicine—hereditary colorectal cancer. N Engl J Med.
2003;348(10):919–32.
18. Robbins DH, Itzkowitz SH. The molecular and
genetic basis of colon cancer. Med Clin North Am.
2002;86(6):1467–95.
19. Winawer SJ, Zauber A, Diaz B. Temporal sequence
of evolving colorectal cancer from the normal colon
(abstr). Gastrointest Endosc. 1987;33:167.
20. Obuch JC, Pigott CM, Ahnen SJ. Sessile serrated
polyps, detection, eradication, and prevention of
the evil twin. Curr Treat Options Gastroenterol.
2015;13(1):156–70.
21. Pickhardt PJ, Arluk GM. Atlas of gastrointestinal imaging: radiologic-endoscopic correlation.
Philadelphia: Saunders; 2007. p.24.
22. O’Brian MJ. Hyperplastic and serrated polyps
of the colorectum. Gastroenterol Clin North Am.
2007;36:947–68.
23. Lynch syndrome approved by the cancer.net. Editorial
Board, 12/2014. [cited 2022 September 10]. http://
www.cancer.net/cancer- types/lynch- syndrome.
24. Sali L, Falchini M, Taddei A, Mascalchi M. Role
of preoperative CT colonography in patients
with colorectal cancer. World J Gastroenterol.
2014;20(14):3795–803. https://doi.org/10.3748/wjg.
v20.i14.3795.
25. Flor N, Ceretti AP, Luigiano C, Brambillasca P,
Savoldi AP, Verrusio C, Ferrari D.Performance of CT
colonography in diagnosis of synchronous colonic
lesions in patients with occlusive colorectal cancer.
AJR. 2020;214(2):348–54. https://doi.org/10.2214/
AJR.19.21810.
26. Hong N, Park SH. CT colonography in the diagnosis and management of colorectal cancer: emphasis on pre- and post-surgical evaluation. World J
Gastroenterol. 2014;20(8):2014–22. https://doi.
org/10.3748/wjg.v20.i8.2014.
27. Laghi A, Neri E, Regge D.Editorial on the European
Society of Gastrointestinal Endoscopy (ESGE) and
European Society of Gastrointestinal and Abdominal
Radiology (ESGAR) guideline on clinical indications for CT colonography in the colorectal cancer
diagnosis. Radiol Med. 2015;120:1021–3. https://doi.
org/10.1007/s11547- 015- 0537- x.
28. Maupoey Ibáñez J, Pàmies Guilabert J, Frasson M,
Boscà Robledo A, Giner Segura F, García-Granero
XE.Accuracy of CT colonography in the preoperative
staging of colon cancer: a prospective study of 217
patients. Color Dis. 2019;21(10):1151–63. https://doi.
org/10.1111/codi.14724.
29. Kijima S, Sasaki T, Nagata K, et al. Preoperative
evaluation of colorectal cancer using CT colonography, MRI, and PET/CT. World J Gastroenterol.
2014;20(45):16964–75.
30. Cunliffe WJ, Hasieton PS, Tweedie DE, Schoeld
PF. Incidence of synchronous and metachronous
colorectal carcinoma. Br J Surg. 1984;71(12):941–3.
31. Heriot AG, Hicks RJ, Drummond EG, Keck J,
Mackay J, Chen F, Kalff V. Does positron emission tomography change management in primary
rectal cancer? A prospective assessment. Dis Colon
Rectum. 2004;47(4):451–8. https://doi.org/10.1007/
s10350- 003- 0089- 3.
32. Stintzing S.F1000Prime Rep. 2014;6:108. Published
online 2014 Nov 4. [cited 2022 September 17]. http://
www.ncbi.nlm.nih.gov/pmc/articles/PMC4229728/.
https://doi.org/10.12703/P6- 108.
33. SIGN (Scottish Intercollegiate Guidelines Network)
126. 2011. Diagnosis and management of colorectal cancer. A national clinical guideline. [cited 2022
September 17]. http://www.sign.ac.uk/pdf/sign126.pdf.
34. Colorectal cancer: treatment options approved by
the cancer.net Editorial Board, 09/2014. [cited 2022
September 17]. http://www.cancer.net/cancer- types/
colorectal- cancer/treatment- options.
35. Virarkar MK, Swarupa S, Vulasala R, Gupta AV,
Gopireddy DR, Kumar S, Hernandez M, Lall C,

220
https://t.me/medicina_free
J. H. Bortz and H. Friedrich-Nel
Bhosale P.Virtual non-contrast imaging in the abdomen and the pelvis: an overview. Semin Ultrasound CT
MRI. 2022;43(4):293–310. https://doi.org/10.1053/j.
sult.2022.03.004.
36. Ersahin D, Rasla J, Singh A.Dual energy CT applications in oncological imaging. Semin Ultrasound CT
MR. 2022;43(4):344–51. https://doi.org/10.1053/j.
sult.2022.04.004.
37. Sato K, Morohashi H, Tsushima F, Sakamoto Y, Miura
T, Fujita H, Umemura K, Suzuki T, Tsuruta S, Kura
R, Ono S, Aoki M, Hakamada K.Dual energy CT is
useful for the prediction of mesenteric and lateral pelvic lymph node metastasis in rectal cancer. Mol Clin
Oncol. 2019;10(6):625–30. https://doi.org/10.3892/
mco.2019.1834.
38. Özdeniz İ, İdilman İS, Köklü S, Hamaloğlu E, Özmen
M, Akata D, Karçaaltıncaba M.Dual-energy CT characteristics of colon and rectal cancer allows differentiation from stool by dual-source CT.Diagn Interv
Radiol. 2017;23(4):251–6. https://doi.org/10.5152/
dir.2017.16225.
39. Ricci ZJ, Kobi M, Flusberg M, Yee J.CT colonography in review with tips and tricks to improve performance. Semin Roentgenol. 2021;56(2):140–51.
https://doi.org/10.1053/j.ro.2020.07.007.
40. Yang Z, Zhang X, Fang M, Li G, Duan X, Mao J,
Shen J. Preoperative diagnosis of regional lymph
node metastasis of colorectal cancer with quantitative parameters from dual-energy CT. AJR Am
J Roentgenol. 2019;213(1):W17–25. https://doi.
org/10.2214/AJR.18.20843.
41. Qiu L, Hu J, Weng Z, Liu S, Jiang G, Cai X.A prospective study of dual-energy computed tomography for differentiating metastatic and non-metastatic
lymph nodes of colorectal cancer. Quant Imaging Med
Surg. 2021;11(8):3448–59. https://doi.org/10.21037/
qims- 20- 3.
42. Gong HX, Zhang KB, Wu LM, Baigorri BF, Yin Y,
Geng XC, Xu JR, Zhu J. Dual energy spectral CT
imaging for colorectal cancer grading: a preliminary
study. PLoS One. 2016;11(2):e0147756. https://doi.
org/10.1371/journal.pone.0147756.
43. Yu C, Helwig EJ. The role of AI technology in prediction, diagnosis and treatment of colorectal cancer. Artif Intell Rev. 2022;55(1):323–43. https://doi.
org/10.1007/s10462- 021- 10034- y.
44. Rasouli P, Dooghaie Moghadam A, Eslami P,
Aghajanpoor Pasha M, Asadzadeh Aghdaei H,
Mehrvar A, Nezami-Asl A, Iravani S, Sadeghi A,
Zali MR.The role of articial intelligence in colon
polyps detection. Gastroenterol Hepatol Bed Bench.
2020;13(3):191–9.
45. Grosu S, Wesp P, Graser A, Maurus S, Schulz C, etal.
Machine learning–based differentiation of benign and
premalignant colorectal polyps detected with CT colonography in an asymptomatic screening population: a
proof-of-concept study. Radiology. 2021;299:326–35.
https://doi.org/10.1148/radiol.2021202363.
46. Bedrikovetski S, Dudi-Venkata NN, Kroon HM,
Seow W, Vather R, Carneiro G, Moore JW, Sammour
T.Articial intelligence for pre-operative lymph node
staging in colorectal cancer: a systematic review
and meta-analysis. BMC Cancer. 2021;21(1):1058.
https://doi.org/10.1186/s12885- 021- 08773- w.
47. Liang F, Wang S, Zhang K, Liu TJ, Li JN.Development
of articial intelligence technology in diagnosis, treatment, and prognosis of colorectal cancer. World J
Gastrointest Oncol. 2022;14(1):124–52. https://doi.
org/10.4251/wjgo.v14.i1.124.
48. Kacew AJ, Strohbehn GW, Saulsberry L,
Laiteerapong N, Cipriani NA, Kather JN, Pearson
AT. Articial intelligence can cut costs while
maintaining accuracy in colorectal cancer genotyping. Front Oncol. 2021;11:630953. https://doi.
org/10.3389/fonc.2021.630953.
49. Santoro M, Strolin S, Paolani G, Della Gala G,
Bartoloni A, Giacometti C, Ammendolia I, Morganti
AG, Strigari L.Recent applications of articial intelligence in radiotherapy: where we are and beyond.
Appl Sci. 2022;12(7):3223. https://doi.org/10.3390/
app12073223.
50. Ethics and governance of articial intelligence for
health: WHO guidance, 2021.

Colonic Diverticular Disease
https://t.me/medicina_free
JoelH.Bortz
16
16.1 Introduction
Diverticular disease (DD) is the most common
benign colonic abnormality in patients over the
age of 50years, who present for initial screening
studies. The disease is endemic in Western populations; it is therefore considered to be a normal
nding on CTC.It is a common gastrointestinal
(GIT) disorder largely due to dietary factors.
Hence, 50% of all screening adults will show
moderate or severe DD, predominantly in the sigmoid colon, and to a lesser extent in the descending colon and right side of the colon [1]. The
incidence of DD increases with age with equal
prevalence in men and women [2]. Over the last
few decades, the prevalence of DD has increased.
Approximately 40% of adults below the age of
40years have the disease. This rises to 50–70%
in adults up to age of 70years and reaches 85%
in persons 80years or older [1]. Asians are more
prone to develop colonic DD on the right side of
the colon [3].
The following abbreviations are used in the
chapter.
• 2D: two-dimensional
• 3D: three-dimensional
• CO2: carbon dioxide
• CRC: colorectal cancer
J. H. Bortz (*)
LSG Imaging, Los Angeles, CA, USA
• DD: diverticular disease
• DDSS: diverticular disease severity score
• FDA: Food and Drug Administration of the
US
• GIT: gastrointestinal tract
• LLD: left lateral decubitus
• OC: optical colonoscopy
• RLD: right lateral decubitus
• USA: United States of America
16.2 Acute Diverticulitis Is
Contraindicated inaCTC Study
Acute diverticulitis is an absolute contraindication for performance of a CTC study [4] because
it means that a perforation of a diverticulum has
occurred. It may be extremely small. A perforation causes an inammatory reaction in surrounding mesentery due to a leak of faecal material. If
the perforation is larger, this means that greater
amounts of faecal material may leak into the peritoneal cavity causing abscess formation. This is a
serious situation which requires use of antibiotics. If there is a large volume of uid in the
abscess cavity, percutaneous drainage may be
required. Abscess formation may result in loops
of small and large bowel sticking together; this
may eventually result in a stula between them
(colo-enteric) or a stula between colon and
colon (colo-colic) and also between colon and
bladder (colo-vesical) as well as between uterus
and colon (colo-uterine).
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023
J. H. Bortz et al. (eds.), CT Colonography for Radiographers,
https://doi.org/10.1007/978-3-031-30866-6_16
221

222
https://t.me/medicina_free
J. H. Bortz
16.3 Pathogenesis andCause
ofColonic Diverticular
Disease
What is pathogenesis? It is the biologic mechanisms that lead to a disease state. A diverticulum
forms as a result of herniation of the mucus
membrane lining through a defect in the muscular portion of the bowel wall. DD pathogenesis is
thus acquired by herniation (out- pouching) of
mucosa and submucosa through the muscularis
propria in an area of weakness where the nutrient
arteries extend through the submucosa [5].
Figure 16.1 shows outpouching of multiple
diverticula.
The cause of colonic DD is not well understood. Several theories have been mooted [2, 6,
7]. Low bre diets that are high in rened carbo-
hydrates and low in dietary bre result in less
bulky stools that retain less water [5]. This may
alter the GIT transit time and may increase intracolonic pressure. Other causes include disordered
colonic mobility [2], high red meat and low fat
consumption, and frequent use of antiinammatory drugs [7].
16.4 Chronic Diverticular Disease
Pathological Features
There are several features of the disease [6].
• Myochosis (muscle thickening) and elastin
deposition
• Thickening of the circular muscle
• Shortening of the taeniae
• Decreased compliance
• Luminal narrowing.
16.5 Severity Score ofDiverticular
Disease
Literature does include a GDD severity score
(DDSS) from 1 to 4 for CTC studies [8]. The
score is based on the maximum wall thickness
and minimum lumen diameter. For example,
DDSS 1 = maximum wall thickness of <3 mm
and minimum lumen diameter of ≥15 mm and
DDSS 4=≥8mm and <5mm, respectively [8].
However, to determine a DDSS requires intravenous administration of 100ml of non-ionic contrast media followed by a 50 ml saline ush
immediately after the standard CTC study in
order to obtain images during the portal venous
stage [8].
Fig. 16.1 Example of outpouching of diverticula (open
white arrows) on supine colon-map view
16.6 CTC inPatients
withDiverticular Disease
Patients with DD are usually asymptomatic
when presenting for CTC screening for detection of colorectal cancer (CRC). Moderate or
advanced severity DD is diagnosed in at least
50% of patients who are 50years or older [9].
The sigmoid colon, followed by the descending
colon, and then the ascending colon, are mainly
the areas of involvement. According to
Pickhardt and Kim [10] in view of its high prevalence, it is not surprising that the disease represents the leading cause of non-diagnostic
segmental evaluation at CTC. Diverticula are

16 Colonic Diverticular Disease
https://t.me/medicina_free
223
not problematic in terms of a reader being able
to diagnose the disease on CTC studies (see
Fig. 16.2a (i) and (ii)). However, inadequate
lumen distension, as discussed in Sect. 16.9,
and thickened folds may cause possible pitfalls,
as discussed in Sect. 12.2.3. Diverticula may
a(i) a(ii)
become lled with inspissated stool and/or barium. When this happens, the diverticula may
then bulge into the colonic lumen causing a polypoidal defect on 3D endoluminal views.
Figure16.2b (i)–d (ii) are examples of impacted
diverticula.
b(i) b(ii)
Fig. 16.2 (a) (i) 3D view of multiple diverticula lled
with barium and air (open black arrows). (ii) 2D axial
view of multiple diverticula (red circle). (b) (i) 3D view
showing diverticulum (black arrow) and impacted diver-
ticulum (green arrow). Polypoidal defect due to stool
(white arrow). (ii) 2D axial view shows stool (white
arrow) and impacted diverticulum (green arrow). Yellow
arrow shows diverticulum.

224
https://t.me/medicina_free
J. H. Bortz
c(i)b(iii)
d(i)c(ii)
d(ii)
Fig. 16.2
ula lled with barium (open red arrow). (c) (i) 3D view of
polypoidal lesion due to polyp (open black arrows) and
uncomplicated diverticula (open white arrows). (ii) 2 D
axial showing impacted diverticulum (green arrow) and
(iii) 2D coronal view shows multiple divertic-
an air-lled diverticulum (red arrow). (d) (i) 3D endoluminal view of impacted diverticulum (white arrow) and
diverticulum (black arrow). (ii) 2D axial shows impacted
diverticula (green arrows) and air-lled diverticulum (red
arrow)

16 Colonic Diverticular Disease
https://t.me/medicina_free
225
16.7 Visualisation ofDiverticula
on2D and3D CTC Images
Most sigmoid diverticula are associated with
thickening of the circular muscle layer and shortened taeniae (myochosis). This may result in
luminal narrowing and an ‘accordion-like appearance’ [11]. The thickening of the folds as well as
luminal narrowing, due to muscular hypertrophy
from DD, can cause a confusing picture on both
2D (two-dimensional) as well as 3D (threedimensional) visualisation. Thick folds may be
interpreted as polyps or even possible masses on
a(i) a(ii)
both 2D and 3D endoluminal views [12]. If in
doubt, an additional view in the right lateral
decubitus (RLD) position, may resolve the image
interpretation issue. The presence of mucosal
prolapse may also prevent a correct diagnosis
being made. Such a prolapse results in a thickened redundant fold which may be impossible to
distinguish from a true polyp.
Diverticula are easily diagnosed in both 2D
and 3D endoluminal views. On 3D views, the orices are surrounded by a recognisable black ring
(Fig. 16.3a (i)). On 2D views, the diverticulum
extends beyond the colon wall and is usually
a(iii)
Fig. 16.3 (a) (i) 3D view shows orice of diverticulum as a black ring (open white arrow). (ii) 3D view of a narrow
neck diverticulum (open black arrows). (iii) 3D view of a wide neck diverticulum (open black arrows)
Соседние файлы в папке @xirurgi_2025
